Cargando…

Epigenomic mapping identifies an enhancer repertoire that regulates cell identity in bladder cancer through distinct transcription factor networks

Muscle-invasive bladder cancer (BLCA) is an aggressive disease. Consensus BLCA transcriptomic subtypes have been proposed, with two major Luminal and Basal subgroups, presenting distinct molecular and clinical characteristics. However, how these distinct subtypes are regulated remains unclear. We hy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Neyret-Kahn, Hélène, Fontugne, Jacqueline, Meng, Xiang Yu, Groeneveld, Clarice S., Cabel, Luc, Ye, Tao, Guyon, Elodie, Krucker, Clémentine, Dufour, Florent, Chapeaublanc, Elodie, Rapinat, Audrey, Jeffery, Daniel, Tanguy, Laura, Dixon, Victoria, Neuzillet, Yann, Lebret, Thierry, Gentien, David, Davidson, Irwin, Allory, Yves, Bernard-Pierrot, Isabelle, Radvanyi, François
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162941/ https://www.ncbi.nlm.nih.gov/pubmed/36944729 http://dx.doi.org/10.1038/s41388-023-02662-1

Ejemplares similares

IGF1R activation and the in vitro antiproliferative efficacy of IGF1R inhibitor are inversely correlated with IGFBP5 expression in bladder cancer
por: Neuzillet, Yann, et al.
Publicado: (2017)

Integrated molecular and pharmacological characterization of patient-derived xenografts from bladder and ureteral cancers identifies new potential therapies
por: Lang, Hervé, et al.
Publicado: (2022)

TYRO3 as a molecular target for growth inhibition and apoptosis induction in bladder cancer
por: Dufour, Florent, et al.
Publicado: (2019)

A Novel Epigenetic Phenotype Associated With the Most Aggressive Pathway of Bladder Tumor Progression
por: Vallot, Céline, et al.
Publicado: (2011)

Deregulation of Rab and Rab Effector Genes in Bladder Cancer
por: Ho, Joel R., et al.
Publicado: (2012)

An FGFR3/MYC positive feedback loop provides new opportunities for targeted therapies in bladder cancers
por: Mahe, Mélanie, et al.
Publicado: (2018)

Identification of targeted therapy for an aggressive subgroup of muscle-invasive bladder cancers
por: Lebret, Thierry, et al.
Publicado: (2015)

Tyro3 Targeting as a Radiosensitizing Strategy in Bladder Cancer through Cell Cycle Dysregulation
por: Silina, Linda, et al.
Publicado: (2022)

An essential role for decorin in bladder cancer invasiveness
por: El Behi, Mohamed, et al.
Publicado: (2013)

Recurrent activating mutations of PPARγ associated with luminal bladder tumors
por: Rochel, Natacha, et al.
Publicado: (2019)

A prospective multicenter study on bladder cancer: the COBLAnCE cohort
por: Benhamou, Simone, et al.
Publicado: (2016)

Analysis of the copy number profiles of several tumor samples from the same patient reveals the successive steps in tumorigenesis
por: Letouzé, Eric, et al.
Publicado: (2010)

Analysis of the copy number profiles of several tumor samples from the same patient reveals the successive steps in tumorigenesis
por: Letouzé, Eric, et al.
Publicado: (2010)

Identification of new driver and passenger mutations within APOBEC-induced hotspot mutations in bladder cancer
por: Shi, Ming-Jun, et al.
Publicado: (2020)

Refining the Characterization and Outcome of Pathological Complete Responders after Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Lessons from the Randomized Phase III VESPER (GETUG-AFU V05) Trial
por: Culine, Stéphane, et al.
Publicado: (2023)

Reference-free transcriptome exploration reveals novel RNAs for prostate cancer diagnosis
por: Pinskaya, Marina, et al.
Publicado: (2019)

Correction: Integrative Modelling of the Influence of MAPK Network on Cancer Cell Fate Decision
por: Grieco, Luca, et al.
Publicado: (2013)

Integrative Modelling of the Influence of MAPK Network on Cancer Cell Fate Decision
por: Grieco, Luca, et al.
Publicado: (2013)

Design of a randomized controlled phase III study of dose dense methotrexate, vinblastine, doxorubicin and cisplatin (dd-MVAC) or gemcitabine and cisplatin (GC) as peri-operative chemotherapy for patients with locally advanced transitional cell cancer of the bladder. The French GETUG/AFU V05 VESPER trial
por: Pfister, Christian, et al.
Publicado: (2020)

Effects of Adenosine Monophosphate Used in Combination with L-Arginine on Female Rabbit Corpus Cavernosum Tissue
por: Stücker, Olivier, et al.
Publicado: (2014)

Expansion of the enzymatic repertoire of the CAZy database to integrate auxiliary redox enzymes
por: Levasseur, Anthony, et al.
Publicado: (2013)

A review of new hormonal therapies for prostate cancer in black men: is there enough data?
por: Meunier, Matthias E., et al.
Publicado: (2021)

The dog and rat olfactory receptor repertoires
por: Quignon, Pascale, et al.
Publicado: (2005)

Inhibition of PI3K pathway increases immune infiltrate in muscle-invasive bladder cancer
por: Borcoman, Edith, et al.
Publicado: (2019)

Seabird’s cry: repertoire and vocal expression of contextual valence in the little auk (Alle alle)
por: Osiecka, Anna N., et al.
Publicado: (2023)

A Case-Only Genome-Wide Interaction Study of Smoking and Bladder Cancer Risk: Results from the COBLAnCE Cohort
por: Karimi, Maryam, et al.
Publicado: (2023)

Comparison of the canine and human olfactory receptor gene repertoires
por: Quignon, Pascale, et al.
Publicado: (2003)

A Meta-Analysis of the Relationship between FGFR3 and TP53 Mutations in Bladder Cancer
por: Neuzillet, Yann, et al.
Publicado: (2012)

HORMAD1 overexpression predicts response to anthracycline–cyclophosphamide and survival in triple‐negative breast cancers
por: El‐Botty, Rania, et al.
Publicado: (2023)

Plasmodium falciparum proteome changes in response to doxycycline treatment
por: Briolant, Sébastien, et al.
Publicado: (2010)

A Repertoire of Clinical Non-Dermatophytes Moulds
por: Menu, Estelle, et al.
Publicado: (2023)

A Repertoire of the Less Common Clinical Yeasts
por: Menu, Estelle, et al.
Publicado: (2023)

A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
por: Kamoun, Aurélie, et al.
Publicado: (2019)

Gene List significance at-a-glance with GeneValorization
por: Brancotte, Bryan, et al.
Publicado: (2011)

Colorectal Cancer and Immunity: From the Wet Lab to Individuals
por: Pramil, Elodie, et al.
Publicado: (2021)

Impact of Experimental Tonic Pain on Corrective Motor Responses to Mechanical Perturbations
por: Traverse, Elodie, et al.
Publicado: (2020)

Somatosensory deficits and neural correlates in cerebral palsy: a scoping review
por: Brun, Clémentine, et al.
Publicado: (2021)

A new tumorgraft panel to accelerate precision medicine in prostate cancer
por: Béraud, Claire, et al.
Publicado: (2023)

Review of Experimental Studies to Improve Radiotherapy Response in Bladder Cancer: Comments and Perspectives
por: Silina, Linda, et al.
Publicado: (2020)

Time for the epigenome
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_9uh49s00c9g2gfdo9gqgptb4qo